| Biomarker ID | 1213 |
| PMID | 24065480 |
| Year | 2013 |
| Biomarker | Methylation Status of HIST1H4K |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Urine |
| Subjects | Humans |
| Regulation | Hypermethylated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Type II interferon signaling (interferon-gamma), Systemic lupus erythematosus |
| Experiment | Prostate Cancer Vs Normal Prostate |
| Type of Biomarker | Diagnostic |
| Cohort | 57 PC patients, 29 controls with be- nign prostatic hyperplasia (BPH) and 50 young asymptomatic men (YAM) were investigated |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.763; 95% CI: (0.672-0.839) |
| Accuracy | NA |
| Level Of Significance | p<0.0001 |
| Method Used | RT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |